Synapsoft logo
AI Insights from Disclosures
Searching...
CELLUMED CO., LTD. 049180
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
CELLUMED CO., LTD., the controlling company, engages in businesses such as medical devices, Biologics, and Cosmeceutical. In its medical devices business, the company handles Tissue Engineering, which researches and develops demineralized bone matrix (DBM) and knee cartilage (BMG), among others, as well as artificial knee joints (TKR) and allografts, while in its Biologics segment, it manufactures and distributes growth factors (recombinant proteins) such as bone morphogenetic protein (rhBMP2) and a synovial fluid substitute (VISCOSEAL).
Representative Director Yu Insu
Founded April 30, 1985
Corporation Type KOSDAQ
Industry Classification Manufacture of medicinal chemicals
Corporate number 12011-0019225
Business number 134-81-01408
Phone Number 02-3281-0471
Fax Number 02-2104-0478
Company Address 130 Digital-ro, Geumcheon-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant